These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7164016)

  • 1. The effect of oral contraceptives on coagulation and fibrinolytic parameters in the Chinese--a prospective study.
    Wong V; Chan TK; Chan V; Tso SC; Todd D; Ma HK
    Thromb Haemost; 1982 Dec; 48(3):263-5. PubMed ID: 7164016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
    Ferreira AC; Montes MB; Franceschini SA; Toloi MR
    Int J Fertil Womens Med; 2001; 46(5):265-70. PubMed ID: 11720199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrelationship between oral contraceptives and some parameters of the coagulative-fibrinolytic function (author's transl).
    Chieffi O; Brogioni M; Saltarelli O; Pecchioli S; Benardi M
    Patol Clin Ostet Ginecol; 1981; 9(2):164-72. PubMed ID: 12278647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemostatic balance during treatment with the newest contraceptives].
    Petersen KR; Skouby SO; Sidelmann J; Jespersen J
    Ugeskr Laeger; 1994 Jan; 156(2):187-90. PubMed ID: 8296409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
    Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
    Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual levels of plasma alpha 2-antiplasmin and alpha 2-macroglobulin during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
    Jespersen J; Sidelmann J
    Thromb Haemost; 1983 Aug; 50(2):581-5. PubMed ID: 6195752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balance of coagulation activity with fibrinolysis during use of oral contraceptives in women with insulin-dependent diabetes mellitus.
    Petersen KR; Skouby SO; Jespersen J
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():105-11. PubMed ID: 8574252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum antithrombin III and alpha-2-antiplasmin concentration in patients with lung carcinoma.
    Dabrowska M; Prokopowicz J; Kemona H; Kretowska J; Kulik S; Głuszczak M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(5):641-6. PubMed ID: 2465244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
    Middeldorp S; Meijers JC; van den Ende AE; van Enk A; Bouma BN; Tans G; Rosing J; Prins MH; Büller HR
    Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of coagulation in smoking and non-smoking women using a third-generation oral contraceptive containing desogestrel.
    Fruzzetti F; De Negri F; Morale M; Ricci C; Ferrini L; Bersi C; Genazzani AR; Carmassi F
    Eur J Contracept Reprod Health Care; 1999 Sep; 4(3):113-8. PubMed ID: 10574636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of platelet activation, plasma antithrombin III and alpha2-antiplasmin activities in hypertensive patients.
    Tomczykowska M; Bielak J; Bodys A
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):15-20. PubMed ID: 15314952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters.
    Wiegratz I; Stahlberg S; Manthey T; Sänger N; Mittmann K; Lange E; Mellinger U; Kuhl H
    Contraception; 2008 Nov; 78(5):384-91. PubMed ID: 18929735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation and fibrinolytic reactions in experimental porcine septic shock: pretreatment with different antiplatelet factors.
    Svartholm E; Bergqvist D; Haglund U; Ljungberg J; Hedner U
    Circ Shock; 1987; 22(4):291-301. PubMed ID: 2443265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of hormonal contraceptives on the coagulation system with special reference to its inhibitors].
    Misz M; Beck P; Flóra-Nagy M
    Orv Hetil; 1985 Oct; 126(43):2635-40. PubMed ID: 4058912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of long-term using once-a-month injectable contraceptive norethisterone enanthate/estradiol valerate on coagulation in the Chinese.
    Meng YX; Jiang HY; Lu FY
    Thromb Haemost; 1990 Dec; 64(4):548-9. PubMed ID: 2084940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural oestrogen in the female climacteric--influence on blood coagulation and fibrinolysis.
    Lagrelius A; Lunell NO; Blombäck M
    Thromb Haemost; 1979 Feb; 40(3):532-41. PubMed ID: 154749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.